Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

All Markets Earnings Economy Technology IPO Crypto Commodities Forex Analysis Regulation
T1 Energy Hits 52-Week High on $32M KORE Power Acquisition
Markets Daniel Marsh

T1 Energy Hits 52-Week High on $32M KORE Power Acquisition

T1 Energy shares hit a 52-week high after agreeing to buy KORE Power for $32 million, moving into battery storage and AI data center power.

FSLR ENPH SEDG
Merck Shares Jump as New Drug Data Eases Keytruda Concerns
Markets Daniel Marsh

Merck Shares Jump as New Drug Data Eases Keytruda Concerns

Merck shares surged 4.9% to $120.26 after ASCO data showed its new cancer drug sac-TMT combined with Keytruda improved progression-free survival, reinforcing confidence in the post-Keytruda pipeline.

MRK UNH BMY GILD AZN SNY
Patterson-UTI Rises on Strong Drilling Outlook Despite Oil Decline
Markets Daniel Marsh

Patterson-UTI Rises on Strong Drilling Outlook Despite Oil Decline

Patterson-UTI shares rose 3.1% as the company projected higher rig counts and $220M in Q2 adjusted EBITDA, despite a 3% drop in oil prices and historically low DUC wells.

PTEN HAL BKR SLB USO SPY
Comcast Stock Dips Again as UK Park Plan and $4B Debt Deal Weigh
Markets Daniel Marsh

Comcast Stock Dips Again as UK Park Plan and $4B Debt Deal Weigh

Comcast shares dropped 1.1% to $23.26, extending a 5.35% decline, as the market reacts to a £5 billion UK resort plan, a $4.14 billion debt buyback, and Peacock's profitability milestone.

CMCSA SPY XLC DIS NFLX CHTR
Dow Hits Record as Oil Slumps; AI Chip Concerns Curb Nasdaq
Markets Daniel Marsh

Dow Hits Record as Oil Slumps; AI Chip Concerns Curb Nasdaq

Dow hits record as healthcare and financials rally, but Broadcom's 11% plunge on flat AI outlook caps Nasdaq. Oil drops 3% on ceasefire hopes.

UNH AVGO NVDA TSM MRVL USO XLV XLF
Dow Hits Record as Oil Retreats, Healthcare Surges; Broadcom Disappoints
Markets Daniel Marsh

Dow Hits Record as Oil Retreats, Healthcare Surges; Broadcom Disappoints

The Dow rose 1.60% to a record 51,496.83 as oil prices eased and hopes for an end to the Iran war lifted healthcare and financial shares, offsetting weakness in AI stocks led by Broadcom.

UNH GS AVGO NVDA TSM GLD USO SPY QQQ DIA
Blue Owl Capital Shares Surge as Private Credit Worries Ease
Markets Daniel Marsh

Blue Owl Capital Shares Surge as Private Credit Worries Ease

Blue Owl shares surged 5.5% to $10.225 as private-credit asset managers rebounded after Blackstone's withdrawal cap eased redemption fears. The sector remains under watch.

OWL BX ARES APO SPY
Oscar Health Jumps 15% on Wells Fargo Upgrade Citing Better Exchange Outlook
Markets Daniel Marsh

Oscar Health Jumps 15% on Wells Fargo Upgrade Citing Better Exchange Outlook

Oscar Health shares surged 15.5% to $23.68 after Wells Fargo upgraded the stock to Equal Weight, citing improved 2026 exchange trends but limited visibility beyond this year.

OSCR UNH CNC ELV
Grab Holdings Rises as Nasdaq Slips; Fintech Growth in Focus
Markets Daniel Marsh

Grab Holdings Rises as Nasdaq Slips; Fintech Growth in Focus

Grab Holdings shares rose 2.9% on Thursday, bouncing from prior losses, as the market evaluates its Q1 results and fintech expansion amid sector headwinds.

GRAB UBER LYFT
Goldman Sachs Surge Lifts Dow to Record High Amid Financial Sector Rotation
Markets Daniel Marsh

Goldman Sachs Surge Lifts Dow to Record High Amid Financial Sector Rotation

Goldman Sachs shares surged 4.6% to $1,095.89, pushing the Dow to a record high as financial stocks rallied. The bank's lead underwriting of SpaceX's $75B IPO and solid Q1 results boosted sentiment.

GS JPM MS SPY QQQ XLF
Veru Stock Surges on Novo Nordisk Obesity Trial Collaboration
Markets Daniel Marsh

Veru Stock Surges on Novo Nordisk Obesity Trial Collaboration

Veru shares surged 112% to $4.78 after Novo Nordisk will provide Wegovy for Veru's Phase 2b obesity trial. Analysts kept $24-$25 targets, but Veru warned of trial risks and reimbursement challenges.

VERU NVO
CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally
Markets Daniel Marsh

CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally

CRISPR Therapeutics shares surged 12% in New York trading, buoyed by a sector-wide gene-editing rally and Eli Lilly's $1.9 billion deal with Ascidian Therapeutics.

CRSP LLY NTLA BEAM EDIT XBI